Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $9.7 million.

  • Bioharvest Sciences' Cash from Financing Activities rose 603658.54% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year increase of 5613.59%. This contributed to the annual value of $6.8 million for FY2024, which is 4998.52% down from last year.
  • According to the latest figures from Q3 2025, Bioharvest Sciences' Cash from Financing Activities is $9.7 million, which was up 603658.54% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, Bioharvest Sciences' Cash from Financing Activities peaked at $9.7 million during Q3 2025, and registered a low of -$164000.0 during Q3 2024.
  • Its 3-year average for Cash from Financing Activities is $3.4 million, with a median of $2.5 million in 2024.
  • In the last 5 years, Bioharvest Sciences' Cash from Financing Activities crashed by 11386.31% in 2024 and then surged by 603658.54% in 2025.
  • Bioharvest Sciences' Cash from Financing Activities (Quarter) stood at $7.0 million in 2023, then crashed by 64.99% to $2.5 million in 2024, then soared by 296.74% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q3 2025, $2.4 million for Q2 2025, and $3.1 million during Q1 2025.